GALINA SERDTSEV: Open Payments
NPI 1902916208 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 25 payments from 7 companies in 2025. Trend: 2023 $561 · 2024 $535 · 2025 $507
Food & beverage: $412Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $203 |
| GENZYME CORPORATION | 6 | $151 |
| ABBVIE INC. | 3 | $64 |
| Incyte Corporation | 1 | $28 |
| Lilly USA, LLC | 1 | $22 |
| LEO Pharma Inc. | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $19 |
Products named: TREMFYA, DUPIXENT, RINVOQ, Opzelura, TALTZ, ADBRY, NEMLUVIO.
Industry payments across NV — which companies pay providers there.
